Gene: CDRT15
Official Full Name: CMT1A duplicated region transcript 15provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23964 | CDRT15 Knockout cell line (HEK293) | Human | CDRT15 | 1:3~1:6 | Negative | Online Inquiry |
CDRT15 Gene Knockout Cell Lines represent a pioneering innovation in genetic research, specifically designed to facilitate the study of gene function and regulation. These cell lines have been developed using CRISPR-Cas9 technology to induce a targeted knockout of the CDRT15 gene, which is implicated in various biological processes and diseases. By eliminating the expression of this gene, researchers are able to observe the resultant phenotypic changes, allowing for intricate studies on gene function, pathway analysis, and potential therapeutic interventions.
The primary function of the CDRT15 knockout is to disrupt normal cellular processes, providing researchers with critical insights into the role of CDRT15 in cellular pathways and disease mechanisms. The implementation of CRISPR-Cas9 allows for precise genomic editing, enabling the generation of stable and reproducible cell lines that can be utilized for a variety of applications including drug screening, gene therapy research, and understanding complex disease states like cancer or metabolic disorders.
This product is of significant scientific importance in both research and clinical settings due to its capability to mimic disease states by specifically knocking out target genes. By using CDRT15 knockout cell lines, scientists can explore alternative pathways and validate target genes for therapeutic development, thereby facilitating breakthroughs in understanding and treating diseases.
Compared to other available gene knockout models, CDRT15 cell lines showcase unique advantages such as their high efficiency of gene disruption and stable integration, ensuring that researchers obtain consistent results across experiments. Furthermore, these cell lines are readily available and easy to use, which minimizes the barriers to entry for laboratories that may not have extensive resources for gene editing.
The CDRT15 Gene Knockout Cell Lines are an invaluable tool for researchers and clinicians committed to expanding the horizons of genetic research and therapeutic development. These cell lines not only enhance the relevance of experimental models in preclinical studies but also empower scientists to innovate within their respective fields.
At our company, we pride ourselves on our deep expertise in genetic technologies and biologics. Our commitment to providing high-quality biological products ensures that researchers have access to reliable tools that can significantly impact their work and advance the frontier of scientific understanding.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.